Efficacy and Safety of Incobotulinumtoxina in the Combined Treatment of Upper Facial Lines
Phase of Trial: Phase III
Latest Information Update: 25 May 2015
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Facial-wrinkles; Glabellar lines; Skin aging
- Focus Therapeutic Use
- 25 May 2015 Primary efficacy endpoints met; All response rate significant with Botulinum toxin when compared with placebo.
- 25 May 2015 New trial record
- 24 Mar 2015 Results presented at the 73rd Annual Meeting of the American Academy of Dermatology.